Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,211 | 184 | 54.5% |
| Consulting Fee | $3,600 | 2 | 37.7% |
| Travel and Lodging | $626.55 | 3 | 6.6% |
| Education | $122.92 | 13 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $5,228 | 34 | $0 (2023) |
| ABBVIE INC. | $1,597 | 51 | $0 (2023) |
| PFIZER INC. | $338.56 | 24 | $0 (2023) |
| AMAG Pharmaceuticals, Inc. | $320.09 | 12 | $0 (2020) |
| Vertical Pharmaceuticals, LLC | $274.44 | 20 | $0 (2019) |
| Sumitomo Pharma America, Inc. | $267.50 | 8 | $0 (2024) |
| Gilead Sciences, Inc. | $264.28 | 3 | $0 (2019) |
| Lupin Inc. | $248.52 | 8 | $0 (2020) |
| Myovant Sciences Inc. | $213.95 | 5 | $0 (2022) |
| MAYNE PHARMA COMMERCIAL LLC | $143.11 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $219.30 | 7 | MAYNE PHARMA COMMERCIAL LLC ($143.11) |
| 2023 | $447.05 | 17 | Sumitomo Pharma America, Inc. ($247.38) |
| 2022 | $460.80 | 19 | ABBVIE INC. ($297.21) |
| 2021 | $834.67 | 26 | AbbVie Inc. ($545.59) |
| 2020 | $354.45 | 17 | AbbVie Inc. ($169.01) |
| 2019 | $5,612 | 36 | Amgen Inc. ($4,700) |
| 2018 | $690.37 | 26 | Amgen Inc. ($228.63) |
| 2017 | $941.66 | 54 | PFIZER INC. ($243.82) |
All Payment Transactions
202 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Solta Medical, a division of Bausch Health US, LLC | CLEAR+BRILLIANT | Food and Beverage | In-kind items and services | $22.38 | General |
| 06/05/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: HORMONE THERAPY | ||||||
| 04/15/2024 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Food and Beverage | In-kind items and services | $118.03 | General |
| Category: CONTRACEPTIVE | ||||||
| 04/08/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $9.85 | General |
| 04/03/2024 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 02/21/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $15.23 | General |
| 01/17/2024 | Hologic Sales and Service, LLC | THINPREP 2000 PROCESSOR (Device), APTIMA | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diagnostics | ||||||
| 12/07/2023 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: WOMENS HEALTH | ||||||
| 11/03/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: HORMONE THERAPY | ||||||
| 09/18/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HORMONE THERAPY | ||||||
| 09/06/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: HORMONE THERAPY | ||||||
| 07/20/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: HORMONE THERAPY | ||||||
| 07/20/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: HORMONE THERAPY | ||||||
| 07/12/2023 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 07/05/2023 | ABBVIE INC. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: WOMENS HEALTH | ||||||
| 06/07/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Bone Health | ||||||
| 05/18/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Urology | ||||||
| 05/18/2023 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 05/10/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Urology | ||||||
| 04/12/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: HORMONE THERAPY | ||||||
| 03/15/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: HORMONE THERAPY | ||||||
| 03/08/2023 | ABBVIE INC. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: WOMENS HEALTH | ||||||
| 02/01/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, PAXLOVID | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: WOMENS HEALTH | ||||||
| 01/25/2023 | ABBVIE INC. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: WOMENS HEALTH | ||||||
| 12/14/2022 | ABBVIE INC. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 243 | 317 | $88,578 | $29,505 |
| 2022 | 5 | 200 | 237 | $66,600 | $22,807 |
| 2021 | 4 | 224 | 258 | $76,437 | $25,437 |
| 2020 | 4 | 168 | 195 | $59,450 | $17,379 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 88 | 96 | $24,000 | $10,445 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 127 | $31,750 | $10,223 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 45 | $22,500 | $4,974 | 22.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 12 | 12 | $3,000 | $1,780 | 59.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $6,600 | $1,665 | 25.2% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2023 | 21 | 26 | $728.00 | $418.46 | 57.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 121 | $30,250 | $9,388 | 31.0% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 72 | 78 | $19,500 | $9,046 | 46.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $6,600 | $1,624 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 14 | $7,000 | $1,582 | 22.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $3,250 | $1,167 | 35.9% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 88 | 92 | $22,887 | $10,844 | 47.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 97 | 127 | $31,750 | $9,628 | 30.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $13,800 | $3,277 | 23.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 16 | $8,000 | $1,687 | 21.1% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 67 | 69 | $17,250 | $7,806 | 45.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 90 | $22,500 | $5,387 | 23.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $10,200 | $2,210 | 21.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 19 | $9,500 | $1,975 | 20.8% |
About Helen Hsieh
Helen Hsieh is a Specialist healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609857382.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Helen Hsieh has received a total of $9,560 in payments from pharmaceutical and medical device companies, with $219.30 received in 2024. These payments were reported across 202 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($5,211).
As a Medicare-enrolled provider, Hsieh has provided services to 835 Medicare beneficiaries, totaling 1,007 services with total Medicare billing of $95,128. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Flushing, NY
- Active Since 11/09/2005
- Last Updated 11/16/2011
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609857382
Products in Payments
- Prolia (Biological) $5,003
- ORIAHNN (Drug) $549.30
- MYFEMBREE (Drug) $481.45
- Orilissa (Drug) $461.46
- ORILISSA (Drug) $422.26
- INTRAROSA (Drug) $285.97
- PVC (Drug) $243.82
- DIVIGEL (Drug) $231.37
- SOLOSEC (Drug) $227.64
- EVENITY (Biological) $224.84
- Vemlidy (Drug) $123.49
- NEXTSTELLIS (Drug) $118.03
- PREMARIN (Drug) $94.74
- LO LOESTRIN FE (Drug) $88.66
- Twirla (Drug) $56.01
- IMVEXXY (Drug) $55.04
- Lupron (Drug) $52.96
- Myrbetriq (Drug) $48.24
- Paragard (Device) $39.21
- ANNOVERA (Drug) $35.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Flushing
Dr. George Juang, Md, MD
Specialist — Payments: $266,218
Daniel Skupski, Md, MD
Specialist — Payments: $16,957
Dr. Zeyar Thet, Md, MD
Specialist — Payments: $15,422
Meyer Gershbaum, Md, MD
Specialist — Payments: $15,197
Dr. June Yin, Md, MD
Specialist — Payments: $10,590
King-Chen Hon, M.d, M.D
Specialist — Payments: $5,249